Skeletal regenerative medicine promises to mitigate age-related bone loss and support fracture healing but requires manipulation of biological properties of osteogenic progenitor cells. Osteogenic cells must sustain their phenotype during lineage-expansion yet undergo a number of mitotic cell cycles to generate the requisite number of cells for proper tissue-organization. The proposed study will examine fundamental mechanisms that ensure cells retain a post-mitotic molecular memory of the bone phenotype. The central hypothesis of our study is that key mRNAs for osteogenic factors are passed on to daughter cells during mitosis as a component of a non-genomic epigenetic mechanism and that selected microRNAs (miRs) attenuate the translation of these transmitted mRNAs. Our hypothesis is based on a robust set of preliminary data showing that the osteogenic master regulator Runx2 is controlled by mitotic miRs in osteoblastic cell lines. Based on these and other preliminary data, we will (i) characterize the full complement of miRs that suppress expression of Runx2 in proliferating osteogenic cells, as well as begin characterization of mRNAs and cognate miRs during mitosis;(ii) examine miR dependent changes in fidelity of cell growth, survival and lineage-direction in proliferating osteoblasts, and (iii) characterize the physiological role of selected mitosis-related miRs during skeletal development in vivo. Validation of this concept would (i) establish a major new dimension in cell cycle regulation, (ii) reveal a previously unrecognized function for miRs during mitosis, (iii) define a novel molecular mechanism for biological control of gene expression in lineage-committed cells, and (iv) identify specific miRs that are transmitted to osteogenic progeny cells upon mitosis ('mito-miRs'). From a molecular therapeutic perspective, these miRs permit generation of epigenomic agents that control cellular inheritance by targeting cell fate determining factors which mediate mesenchymal stem cell expansion and differentiation.

Public Health Relevance

Bone formation requires expansion and differentiation of osteoprogenitor cells. Osteogenic cells pass on genetic (chromosomes) and epigenetic information (e.g., CpG methylation, histone codes and bookmarking by transcription factors) to progeny cells to maintain growth potential and osteogenic phenotype identity. We will characterize a fundamentally novel RNA based epigenetic mechanism involving mitotic co-transmission of mRNAs and cognate microRNAs during mitosis.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01AR049069-12
Application #
8727255
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Chen, Faye H
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Varela, Nelson; Aranguiz, Alejandra; Lizama, Carlos et al. (2016) Mitotic Inheritance of mRNA Facilitates Translational Activation of the Osteogenic-Lineage Commitment Factor Runx2 in Progeny of Osteoblastic Cells. J Cell Physiol 231:1001-14
Bonin, Carolina A; Lewallen, Eric A; Baheti, Saurabh et al. (2016) Identification of differentially methylated regions in new genes associated with knee osteoarthritis. Gene 576:312-8
Kremers, Hilal Maradit; Lewallen, Eric A; van Wijnen, Andre J et al. (2016) Clinical Factors, Disease Parameters, and Molecular Therapies Affecting Osseointegration of Orthopedic Implants. Curr Mol Biol Rep 2:123-132
Lin, Yang; Lewallen, Eric A; Camilleri, Emily T et al. (2016) RNA-seq analysis of clinical-grade osteochondral allografts reveals activation of early response genes. J Orthop Res 34:1950-1959
Taipaleenmäki, Hanna; Farina, Nicholas H; van Wijnen, Andre J et al. (2016) Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells. Oncotarget :
Camilleri, Emily T; Gustafson, Michael P; Dudakovic, Amel et al. (2016) Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther 7:107
Fang, Dong; Gan, Haiyun; Lee, Jeong-Heon et al. (2016) The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science 352:1344-8
Lewallen, Eric A; Jones, Dakota L; Dudakovic, Amel et al. (2016) Osteogenic potential of human adipose-tissue-derived mesenchymal stromal cells cultured on 3D-printed porous structured titanium. Gene 581:95-106
Getzlaf, Matthew A; Lewallen, Eric A; Kremers, Hilal M et al. (2016) Multi-disciplinary antimicrobial strategies for improving orthopaedic implants to prevent prosthetic joint infections in hip and knee. J Orthop Res 34:177-86
Morhayim, Jess; van de Peppel, Jeroen; Braakman, Eric et al. (2016) Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells. Sci Rep 6:32034

Showing the most recent 10 out of 125 publications